AIRLINK 70.40 Decreased By ▼ -2.66 (-3.64%)
BOP 4.95 Decreased By ▼ -0.14 (-2.75%)
CNERGY 4.33 Decreased By ▼ -0.04 (-0.92%)
DFML 31.33 Decreased By ▼ -1.12 (-3.45%)
DGKC 76.88 Increased By ▲ 1.39 (1.84%)
FCCL 19.90 Increased By ▲ 0.38 (1.95%)
FFBL 34.90 Decreased By ▼ -1.25 (-3.46%)
FFL 9.13 Decreased By ▼ -0.09 (-0.98%)
GGL 9.90 Increased By ▲ 0.05 (0.51%)
HBL 113.52 Decreased By ▼ -3.18 (-2.72%)
HUBC 132.86 Increased By ▲ 0.17 (0.13%)
HUMNL 7.07 Decreased By ▼ -0.03 (-0.42%)
KEL 4.29 Decreased By ▼ -0.12 (-2.72%)
KOSM 4.33 Decreased By ▼ -0.07 (-1.59%)
MLCF 36.47 Increased By ▲ 0.27 (0.75%)
OGDC 133.35 Decreased By ▼ -0.15 (-0.11%)
PAEL 22.45 Decreased By ▼ -0.15 (-0.66%)
PIAA 24.55 Decreased By ▼ -1.46 (-5.61%)
PIBTL 6.51 Decreased By ▼ -0.04 (-0.61%)
PPL 117.20 Increased By ▲ 1.89 (1.64%)
PRL 26.30 Decreased By ▼ -0.33 (-1.24%)
PTC 13.65 Decreased By ▼ -0.45 (-3.19%)
SEARL 52.15 Decreased By ▼ -1.30 (-2.43%)
SNGP 68.90 Increased By ▲ 1.65 (2.45%)
SSGC 10.60 Decreased By ▼ -0.10 (-0.93%)
TELE 8.46 Increased By ▲ 0.04 (0.48%)
TPLP 10.84 Increased By ▲ 0.09 (0.84%)
TRG 59.95 Decreased By ▼ -3.92 (-6.14%)
UNITY 25.10 Decreased By ▼ -0.02 (-0.08%)
WTL 1.29 Increased By ▲ 0.02 (1.57%)
BR100 7,437 Decreased By -24.3 (-0.33%)
BR30 24,075 Decreased By -95.9 (-0.4%)
KSE100 71,052 Decreased By -50.9 (-0.07%)
KSE30 23,374 Decreased By -20.9 (-0.09%)

imagePARIS: French food group Danone said on Friday said it was weighing its compensation options after a false New Zealand milk botulism scare caused it to recall products in eight markets.

The recall will affect its third-quarter earnings in Asia.

On Wednesday, New Zealand said the scare was a false alarm and that tests indicating that products from dairy giant Fonterra contained the potentially fatal bug clostridium botulinum had been incorrect.

The crisis led to infant formula being pulled off shelves from China to Saudi Arabia.

For Danone, it translated into a recall of selected infant formula products in eight of its markets.

In Friday's statement, Danone said it welcomed the new findings, but noted that "these recalls have had a significant impact on the Baby Nutrition division's sales in Asia," adding it is "currently reviewing its recourse and compensation options."

Danone's chief financial officer Pierre-Andre Terisse said that because of the recalls, third-quarter sales in the unit would be down.

But, he said, "we are deploying action plans to restore sales in affected markets. Their success will enable Danone to meet its growth and margin targets for 2013."

Comments

Comments are closed.